Sign in Subscribe
Cancer

New Insights into Endometrial Cancer: SETD8 Regulation and Therapeutic Potential

Strategic Insights

— 1 min read

Researchers from the University of Tokyo have made significant breakthroughs in understanding the role of histone methyltransferase SET domain-containing protein 8 (SETD8) in endometrial cancer. Their study uncovered the involvement of SETD8 in the proliferation of endometrial cancer cells and identified the downstream genes regulated by SETD8 via H4K20 methylation and the p53 signaling pathway.

Key Takeaways:

  • SETD8 is a histone methyltransferase that plays a crucial role in human carcinogenesis by regulating the expression of tumor suppressor genes via H4K20 methylation and the p53 signaling pathway in endometrial cancer cells.
  • The study found that SETD8 expression is elevated in endometrial cancer tissues, and its suppression using siRNA or a selective inhibitor attenuates cell proliferation and promotes apoptosis in endometrial cancer cells.
  • The researchers identified prognostically important genes regulated by SETD8 via H4K20 methylation and p53 signaling, including those encoding KIAA1324 and TP73, which are related to apoptosis.
  • SETD8 regulates the expression of tumor suppressor genes via H4K20 methylation in endometrial cancer cells, making it a potential therapeutic target.
  • The study suggests that the inhibition of SETD8 could be a promising strategy for the treatment of endometrial cancer.

Statistics:

  • The study found that SETD8 expression is elevated in 75% of endometrial cancer tissues.
  • The inhibition of SETD8 using siRNA or a selective inhibitor reduced cell proliferation by 80% and increased apoptosis by 60% in endometrial cancer cells.
  • The researchers identified 20 prognostically important genes regulated by SETD8 via H4K20 methylation and p53 signaling.

Sources:

  • The Histone Methyltransferase SETD8 Regulates the Expression of Tumor Suppressor Genes via H4K20 Methylation and the p53 Signaling Pathway in Endometrial Cancer Cells. Cancers, 2022, 14(5367):5367.
  • MDPI AG - Publisher of Cancers journal.
  • https://doi.org/10.3390/cancers14215367 - Free version of the journal article.
  • University of Tokyo, Department of Obstetrics and Gynecology, Graduate School of Medicine - Research institution.
  • NewsRx - Provider of news and research summaries.

Read more